Company · CIK 0001544116
Durata Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 4/ADurata Therapeutics, Inc.0001209191-14-070148 · 16.3 KBSEC(opens sec.gov)
- 4Insider trades0001209191-14-070105 · 18.4 KBSEC(opens sec.gov)
- 4Insider trades0001209191-14-070103 · 13.0 KBSEC(opens sec.gov)
- 4Insider trades0001209191-14-070093 · 13.3 KBSEC(opens sec.gov)
- 4Insider trades0001209191-14-070089 · 10.9 KBSEC(opens sec.gov)
- SC 13D/ADurata Therapeutics, Inc.0001193125-14-418596 · 60.6 KBSEC(opens sec.gov)
- SC 13D/ADurata Therapeutics, Inc.0000950142-14-002280 · 202.3 KBSEC(opens sec.gov)
- 4Insider trades0001209191-14-069874 · 14.4 KBSEC(opens sec.gov)
- 4Insider trades0001209191-14-069864 · 8.1 KBSEC(opens sec.gov)
- SC 13D/ADurata Therapeutics, Inc.0001193125-14-417773 · 173.1 KBSEC(opens sec.gov)
Insiders
- Ahrens Brenton KarlDirector, 10% Owner
- AISLING CAPITAL III LP10% Owner
- AKKARAJU SRINIVAS10% Owner
- Allen Susan Roberta10% Owner
- Birchler Angela Gurski10% Owner
- BLAIR JAMES C10% Owner
- Canaan Partners VIII LLCDirector, 10% Owner
- Canaan VIII LPDirector, 10% Owner
- CARROLL J MARTINDirector
- Chambon Philippe O.10% Owner
Tickers
No tickers on record.
Addresses
business
200 SOUTH WACKER DRIVE SUITE 2550
CHICAGO, IL, 60606
mailing
200 SOUTH WACKER DRIVE SUITE 2550
CHICAGO, IL, 60606
Same industry